Trial Profile
A trial of Infliximab to check elevated serum IL-17 levels in Crohn's Disease and in healthy volunteers
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 25 Dec 2015
Price :
$35
*
At a glance
- Drugs Infliximab (Primary)
- Indications Crohn's disease
- Focus Pharmacodynamics
- 25 Dec 2015 New trial record